Clinical Trial Update: Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes a Phase 1/2 clinical trial of a vaccine therapy with an immune adjuvant in patients with chronic myeloid leukemia, acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission | Phase 1, Phase 2 | Status: COMPLETED